▲ 14 r/biotech
GSK drinks in Chai Discovery’s AI models after wet-lab validation
fiercebiotech.comu/NotGenentech — 6 days ago
▲ 3 r/biotech
PhRMA launches new legal challenge as CMS brings 'most favored nation' pricing to Medicare Part B
fiercepharma.comu/NotGenentech — 6 days ago
▲ 4 r/biotech
Pfizer's Tukysa snags first-line approval in HER2+ breast cancer maintenance
fiercepharma.comu/NotGenentech — 6 days ago
▲ 9 r/biotech
FDA’s Rasonque review documents pressure RevMed as investors jitter over KRAS subgroup data
fiercepharma.comu/NotGenentech — 6 days ago
▲ 160 r/biotech
9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe
biopharmadive.comu/NotGenentech — 20 days ago
▲ 18 r/biotech
Takeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successes
fiercebiotech.comu/NotGenentech — 1 month ago
▲ 99 r/biotech
Mass. governor makes pre-election pitch to biotechs amid warning early-stage start-ups are 'dying'
fiercebiotech.comu/NotGenentech — 1 month ago
▲ 36 r/biotech
Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
fiercepharma.comu/NotGenentech — 1 month ago
▲ 10 r/biotech
Novartis’ cholesterol-lowering medicine fails Phase 3, clouding Lp(a) horizons
biospace.comu/NotGenentech — 1 month ago
▲ 4 r/biotech
Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic
biospace.comu/NotGenentech — 1 month ago
▲ 6 r/biotech
AstraZeneca’s SERD pill overcomes adcomm defeat to win FDA nod in breast cancer
biospace.comu/NotGenentech — 1 month ago
▲ 4 r/biotech
Trailing rivals, AbbVie scores win with dual-acting myeloma drug
biopharmadive.comu/NotGenentech — 1 month ago
▲ 54 r/biotech
Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint
fiercebiotech.comu/NotGenentech — 1 month ago
▲ 9 r/biotech
Roche sweeps neurology corporate reputation rankings once again
fiercepharma.comu/NotGenentech — 1 month ago
▲ 15 r/biotech
Trump GLP-1 update teases blockbuster annual sales for Lilly from Medicare program: analyst
fiercepharma.comu/NotGenentech — 1 month ago
▲ 59 r/biotech
TScan axes 75% of workforce to make room for solid tumor programs
fiercebiotech.comu/NotGenentech — 1 month ago
▲ 2 r/biotech
White House unveils next round of MFN pricing deals with 9 midsized drugmakers
fiercepharma.comu/NotGenentech — 1 month ago
▲ 22 r/biotech
UPDATED: Novartis halts autoimmune CAR-T trials after 3 deaths, as BMS also pauses studies
fiercebiotech.comu/NotGenentech — 1 month ago
▲ 62 r/biotech
ArsenalBio sheds most of staff in pivot to in vivo CAR-T
fiercebiotech.comu/NotGenentech — 1 month ago
▲ 100 r/biotech
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
biopharmadive.comu/NotGenentech — 1 month ago